Elsevier

Antiviral Research

Volume 99, Issue 3, September 2013, Pages 301-306
Antiviral Research

Short Communication
Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin

https://doi.org/10.1016/j.antiviral.2013.06.002Get rights and content

Highlights

  • NS5 from all 4 DENV serotypes traffics to the nucleus, but to differing degrees.

  • DENV1 and 2 NS5 bind nuclear import proteins with similar affinity.

  • Nuclear import inhibitor, Ivermectin, blocks DENV1–4 replication.

Abstract

Infection by one of the 4 distinct serotypes of dengue virus (DENV) threatens >40% of the world’s population, with no efficacious vaccine or antiviral agent currently available. DENV replication through the virus-encoded nonstructural protein (NS) 5 protein occurs in the infected cell cytoplasm, but NS5 from DENV2 has thus far been shown to localize strongly in the nucleus throughout infection. Here we use specific antibodies cross-reactive with NS5 from DENV1–4 to demonstrate nuclear localization of NS5 from all DENV serotypes for the first time in both infected as well as transfected cells, although to differing extents. The small-molecule inhibitor Ivermectin was inhibitory towards both DENV 1 and 2 NS5 interaction with its nuclear transporter importin α/β in vitro, and protected against infection from DENV1–4. Ivermectin thus has potential in the clinical setting as a dengue antiviral.

Section snippets

Introduction, M&M, Results and Discussion

Dengue virus (DENV), a mosquito-borne human pathogen encompassing 4 distinct but closely related serotypes, is a threat to >40% of the world’s population. It contains a positive-sense, single-stranded RNA genome that is translated and replicated in the host cell cytoplasm, encoding three structural (capsid, pre-membrane/membrane, and envelope) and seven nonstructural (NS) proteins (Lindenbach et al., 2007). The multifunctional NS5 is the most conserved amongst DENV1–4, comprising an N-terminal

Acknowledgements

We thank Lee Chin Chin, Sabrina Koh and Elfin Lim for assistance with phage display and preparation of NS5 antibodies, Zhao Yong Qian and Brendon Hansen for NS5 and IgG expression plasmids, respectively, and Amy Rogers and Cassandra David for technical assistance. This work was supported by the National Health and Medical Research Council Australia (Project Grant ID#606409 and Senior Principal Research Fellowship APP1002486), DUKE-NUS Signature Research Program (funded by the Ministry of

References (35)

Cited by (229)

View all citing articles on Scopus
1

These authors contributed equally as first authors to this work.

2

These authors contributed equally as senior authors to this work.

View full text